BML Investment Partners, L.P. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-10 5:39 pm Purchase |
2024-01-10 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 70,468 4.800% |
1,065 (+1.53%) |
Filing |
| 2023-09-15 12:00 pm Unchanged |
2023-09-15 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 69,403 4.780% |
0 (Unchanged) |
Filing |
| 2023-03-29 11:17 am Purchase |
2023-03-24 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 69,403 8.260% |
10,948 (+18.73%) |
Filing |
| 2022-08-16 08:22 am Purchase |
2022-08-15 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 58,455 7.200% |
4,759 (+8.86%) |
Filing |
| 2022-07-07 08:22 am Purchase |
2022-07-06 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 53,696 9.100% |
896 (+1.70%) |
Filing |
| 2022-05-24 12:19 pm Purchase |
2022-05-24 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 52,800 8.940% |
17,250 (+48.52%) |
Filing |
| 2022-05-04 11:00 am Purchase |
2022-04-26 | 13G | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 35,550 6.000% |
35,550 (New Position) |
Filing |